Progress in understanding of the mechanisms underlying chronic inflammatory skin
disorders, such as atopic dermatitis and psoriasis vulgaris, has led to new treatment options …

An estimated 20–25% of the population is affected by chronic, non-communicable
inflammatory skin diseases. Chronic skin inflammation has many causes. Among the most …

Since the discovery of cytokines as key mediators in inflammation, targeting the cytokine
network has represented a promising therapeutic approach. Psoriasis and atopic dermatitis …

Atopic dermatitis (AD), the most prevalent inflammatory skin disease, is characterized by
robust T-cell activation. The disease has several subtypes, all having a common T helper …

Psoriasis is a common, chronic inflammatory skin disease associated with multi-system
manifestations including arthritis and obesity. Our knowledge of the aetiology of the …

Introduction: Atopic dermatitis (AD) is a common inflammatory skin disease regulated by
genetic and environmental factors. Both skin barrier defects and aberrant immune …

Atopic dermatitis (AD) is the most common inflammatory skin disease, and it is considered a
complex and heterogeneous condition. Different phenotypes of AD, defined according to the …

Atopic dermatitis (AD) and psoriasis are chronic inflammatory skin diseases associated with
a significant cutaneous and systemic burden of disease as well as a poor health-related …

Abstract Purpose of Review The therapeutic response to biologic agents in psoriasis is
significantly higher than observed in psoriatic arthritis (PsA). In this review, specific actions to …

The current state, tools, and applications of personalized medicine with special emphasis on
inflammatory skin diseases like psoriasis and atopic dermatitis are discussed. Inflammatory …